Lisa McGinnis
Overview
Explore the profile of Lisa McGinnis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kudo T, Meireles A, Moncada R, Chen Y, Wu P, Gould J, et al.
Nat Biotechnol
. 2025 Feb;
PMID: 40011638
No abstract available.
2.
Kudo T, Meireles A, Moncada R, Chen Y, Wu P, Gould J, et al.
Nat Biotechnol
. 2024 Oct;
PMID: 39375449
Optical pooled screening (OPS) is a scalable method for linking image-based phenotypes with cellular perturbations. However, it has thus far been restricted to relatively low-plex phenotypic readouts in cancer cell...
3.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Aug;
633(8030):E1.
PMID: 39164390
No abstract available.
4.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 May;
630(8016):E9.
PMID: 38816613
No abstract available.
5.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Mar;
627(8005):E11.
PMID: 38480897
No abstract available.
6.
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al.
Nature
. 2024 Feb;
627(8004):646-655.
PMID: 38418879
Tiragolumab, an anti-TIGIT antibody with an active IgG1κ Fc, demonstrated improved outcomes in the phase 2 CITYSCAPE trial (ClinicalTrials.gov: NCT03563716 ) when combined with atezolizumab (anti-PD-L1) versus atezolizumab alone. However,...
7.
Gallo E, Winslow M, Cante-Barrett K, Radermacher A, Ho L, McGinnis L, et al.
Nature
. 2007 Nov;
450(7170):731-5.
PMID: 18046413
At critical times in development, cells are able to convert graded signals into discrete developmental outcomes; however, the mechanisms involved are poorly understood. During thymocyte development, cell fate is determined...